Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2NETWORK 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 34Lung Neoplasms 29Ovarian Neoplasms 23Carcinoma, Ovarian Epithelial 18Fallopian Tube Neoplasms 15Adenocarcinoma of Lung 14Neuroblastoma 13Central Nervous System Neoplasms 11Squamous Cell Carcinoma of Head and Neck 8Head and Neck Neoplasms 8Brain Neoplasms 8Brenner Tumor 7Adenocarcinoma, Bronchiolo-Alveolar 7Urinary Bladder Neoplasms 6Urethral Neoplasms 5Breast Neoplasms 5Astrocytoma 5Wilms Tumor 4Uterine Cervical Neoplasms 4Prostatic Neoplasms 4Medulloblastoma 4Teratoma 3Radiation Injuries 3Optic Nerve Glioma 3Lymphoma 3Esophageal Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Embryonal 3Carcinoma 3Thymoma 2

Interventions

Taxes 2Paclitaxel 2Carboplatin 2Ramucirumab 1Proton Therapy 1Prednisone 1Octreotide 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Thymoma × Carboplatin × Clear all
NCT03694002 2025-10-30

Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery

SWOG Cancer Research Network

Phase 2 Completed
21 enrolled 17 charts
Thoracic

Thymoma

NCT00010257 2023-06-29

Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma

Eastern Cooperative Oncology Group

Phase 2 Completed
46 enrolled 7 charts
Thoracic

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡